New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes

Translational Research

Volumn 155, Issue 5, 2010, Pages 211-216

  Zhao, Yong ^a   Lin, Brian ^a   Dingeldein, Michael ^a   Guo, Chengshan ^a   Hwang, David ^a   Holterman, Mark J ^b  

^a Section of Endocrinology Diabetes and Metabolism   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AUTOIMMUNITY; CELL REGENERATION; CORD BLOOD STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MECHANICS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 77950798364     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.01.003     Document Type: Review

References (28)

1. Ablamunits V., Sherry N.A., Kushner J.A., and Herold K.C. Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough. Ann N Y Acad Sci 1103 (2007) 19-32
2. Trucco M. Regeneration of the pancreatic beta cell. J Clin Invest 115 (2005) 5-12
3. Zhao Y., Lin B., Darflinger R., Zhang Y., Holterman M.J., and Skidgel R.A. Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. PLoS ONE 4 (2009) e4226
4. Zhao Y., Huang Z., Qi M., Lazzarini P., and Mazzone T. Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell. Immunol Lett 108 (2007) 78-87
5. Uccelli A., Moretta L., and Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8 (2008) 726-736
6. Zhao Y., Wang H., and Mazzone T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 312 (2006) 2454-2464
7. Zhao Y., Huang Z., Lazzarini P., Wang Y., Di A., and Chen M. A unique human blood-derived cell population displays high potential for producing insulin. Biochem Biophys Res Commun 360 (2007) 205-211
8. Bayry J., Lacroix-Desmazes S., Dasgupta S., Kazatchkine M.D., and Kaveri S.V. Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants?. Nat Rev Immunol 8 (2008) 1p
9. Brusko T.M., Wasserfall C.H., Clare-Salzler M.J., Schatz D.A., and Atkinson M.A. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 54 (2005) 1407-1414
10. Bleich D. Umbilical cord blood and type 1 diabetes: a road ahead or dead end?. Diabetes Care 32 (2009) 2138-2139
11. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., and Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29 (1980) 1-13
12. Anderson M.S., and Bluestone J.A. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23 (2005) 447-485
13. Aoki C.A., Borchers A.T., Ridgway W.M., Keen C.L., Ansari A.A., and Gershwin M.E. NOD mice and autoimmunity. Autoimmun Rev 4 (2005) 373-379
14. Brusko T., Wasserfall C., McGrail K., et al. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56 (2007) 604-612
15. Kukreja A., Cost G., Marker J., et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109 (2002) 131-140
16. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., and Tree T.I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54 (2005) 92-99
17. Pop S.M., Wong C.P., Culton D.A., Clarke S.H., and Tisch R. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cell during autoimmune diabetes. J Exp Med 201 (2005) 1333-1346
18. Tritt M., Sgouroudis E., d'Hennezel E., Albanese A., and Piccirillo C.A. Functionalwaning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 57 (2008) 113-123
19. You S., Belghith M., Cobbold S., et al. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54 (2005) 1415-1422
20. Bluestone J.A., Tang Q., and Sedwick C.E. T regulatory cells in autoimmune diabetes: past challenges, future prospects. J Clin Immunol 28 (2008) 677-684
21. Li M.O., and Flavell R.A. TGF-beta: a master of all T cell trades. Cell 134 (2008) 392-404
22. Sanvito F., Herrera P.L., Huarte J., et al. TGF-beta 1 influences the relative development of the exocrine and endocrine pancreas in vitro. Development 120 (1994) 3451-3462
23. Miralles F., Battelino T., Czernichow P., and Scharfmann R. TGF-beta plays a key role in morphogenesis of the pancreatic islets of Langerhans by controlling the activity of the matrix metalloproteinase MMP-2. J Cell Biol 143 (1998) 827-836
24. Voltarelli J.C., Couri C.E., Stracieri A.B., et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297 (2007) 1568-1576
25. Zhao Y., Glesne D., and Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 100 (2003) 2426-2431
26. Kucia M., Zuba-Surma E., Wysoczynski M., et al. Physiological and pathological consequences of identification of very small embryonic like (VSEL) stem cells in adult bone marrow. J Physiol Pharmacol 57 Suppl. 5 (2006) 5-18
27. D'Ippolito G., Diabira S., Howard G.A., Menei P., Roos B.A., and Schiller P.C. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117 (2004) 2971-2981
28. Chao K.C., Chao K.F., Fu Y.S., and Liu S.H. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS ONE 3 (2008) e1451